These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 10861776)

  • 1. On the inclusion of prevalent cases in HIV/AIDS natural history studies through a marker-based estimate of time since seroconversion.
    Geskus RB
    Stat Med; 2000 Jul; 19(13):1753-69. PubMed ID: 10861776
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Estimation of time since exposure for a prevalent cohort.
    Muñoz A; Carey V; Taylor JM; Chmiel JS; Kingsley L; Van Raden M; Hoover DR
    Stat Med; 1992 May; 11(7):939-52. PubMed ID: 1351308
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Maturity of human immunodeficiency virus infection and incubation period of acquired immunodeficiency syndrome in injecting drug users.
    Alcabes P; Muñoz A; Vlahov D; Friedland G
    Ann Epidemiol; 1994 Jan; 4(1):17-26. PubMed ID: 7911376
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The incubation period to AIDS in injecting drug users estimated from prevalent cohort data, accounting for death prior to an AIDS diagnosis.
    Hendriks JC; Satten GA; van Ameijden EJ; van Druten HA; Coutinho RA; van Griensven GJ
    AIDS; 1998 Aug; 12(12):1537-44. PubMed ID: 9727576
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acquired immunodeficiency syndrome (AIDS)-free time after human immunodeficiency virus type 1 (HIV-1) seroconversion in homosexual men. Multicenter AIDS Cohort Study Group.
    Muñoz A; Wang MC; Bass S; Taylor JM; Kingsley LA; Chmiel JS; Polk BF
    Am J Epidemiol; 1989 Sep; 130(3):530-9. PubMed ID: 2669471
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunologic markers of progression to acquired immunodeficiency syndrome are time-dependent and illness-specific.
    Krämer A; Biggar RJ; Hampl H; Friedman RM; Fuchs D; Wachter H; Goedert JJ
    Am J Epidemiol; 1992 Jul; 136(1):71-80. PubMed ID: 1384311
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Estimating the distribution of times from HIV seroconversion to AIDS using multiple imputation. Multicentre AIDS Cohort Study.
    Taylor JM; Muñoz A; Bass SM; Saah AJ; Chmiel JS; Kingsley LA
    Stat Med; 1990 May; 9(5):505-14. PubMed ID: 2190287
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD4 lymphocyte count as a determinant of the time from HIV seroconversion to AIDS and death from AIDS: evidence from the Italian Seroconversion Study.
    Phillips AN; Pezzotti P; Lepri AC; Rezza G
    AIDS; 1994 Sep; 8(9):1299-305. PubMed ID: 7802984
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictors of rapid progression to AIDS in HIV-1 seroconverters.
    Keet IP; Krijnen P; Koot M; Lange JM; Miedema F; Goudsmit J; Coutinho RA
    AIDS; 1993 Jan; 7(1):51-7. PubMed ID: 8095146
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Methods for estimating the AIDS incubation time distribution when date of seroconversion is censored.
    Geskus RB
    Stat Med; 2001 Mar; 20(5):795-812. PubMed ID: 11241577
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A model-based approach to estimate the AIDS-free time distribution in homosexual men using longitudinal data.
    Dunlop DD; Tamhane AC; Chmiel JS; Phair JP
    J Biopharm Stat; 1994 Jul; 4(2):129-46. PubMed ID: 7951270
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The treatment-free incubation period of AIDS in a cohort of homosexual men.
    Hendriks JC; Medley GF; van Griensven GJ; Coutinho RA; Heisterkamp SH; van Druten HA
    AIDS; 1993 Feb; 7(2):231-9. PubMed ID: 8466686
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is the time from HIV seroconversion a determinant of the risk of AIDS after adjustment for updated CD4 cell counts?
    Concerted Action on SeroConversion to AIDS and Death in Europe (CASCADE Collaboration)
    J Acquir Immune Defic Syndr; 2001 Oct; 28(2):158-65. PubMed ID: 11588510
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunologic marker paths for seroconversion: single determinations of immunoglobulin A and beta 2-microglobulin are not adequate to estimate time of HIV infection. Multicohort Analysis Project Workshop. Part II.
    AIDS; 1994 Jul; 8(7):923-33. PubMed ID: 7946101
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Median time from seroconversion to AIDS in Italian HIV-positive haemophiliacs: different parametric estimates.
    Chiarotti F; Palombi M; Schinaia N; Ghirardini A; Bellocco R
    Stat Med; 1994 Jan; 13(2):163-75. PubMed ID: 8122052
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differences in time from HIV seroconversion to CD4+ lymphocyte end-points and AIDS in cohorts of homosexual men.
    Veugelers PJ; Schechter MT; Tindall B; Moss AR; Page KA; Craib KJ; Cooper DA; Coutinho RA; Charlebois E; Winkelstein W
    AIDS; 1993 Oct; 7(10):1325-9. PubMed ID: 7903540
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differences in susceptibility to AIDS development: a cohort study of Danish and American homosexual-bisexual men, 1981 to 1995.
    Melbye M; Begtrup K; Rosenberg PS; Biggar RJ; Goedert JJ; Knudsen K; Andersen PK
    J Acquir Immune Defic Syndr Hum Retrovirol; 1998 Jul; 18(3):270-6. PubMed ID: 9665505
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Progression to acquired immunodeficiency syndrome is influenced by CD4 T-lymphocyte count and time since seroconversion.
    Begtrup K; Melbye M; Biggar RJ; Goedert JJ; Knudsen K; Andersen PK
    Am J Epidemiol; 1997 Apr; 145(7):629-35. PubMed ID: 9098180
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of progression and non-progression in injecting drug users and homosexual men with documented dates of HIV-1 seroconversion. European Seroconverter Study and the Tricontinental Seroconverter Study.
    Prins M; Veugelers PJ
    AIDS; 1997 Apr; 11(5):621-31. PubMed ID: 9108944
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Estimating the 1978-1990 and future spread of human immunodeficiency virus type 1 in subgroups of homosexual men.
    Hoover DR; Muñoz A; Carey V; Chmiel JS; Taylor JM; Margolick JB; Kingsley L; Vermund SH
    Am J Epidemiol; 1991 Nov; 134(10):1190-205. PubMed ID: 1746529
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.